Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research
Autor(a) principal: | |
---|---|
Data de Publicação: | 2011 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Brasileira de Cancerologia (Online) |
Texto Completo: | https://rbc.inca.gov.br/index.php/revista/article/view/654 |
Resumo: | Introdution: For a clinical trial to be properly, safely and efficiently conducted, it is necessary that research integrity be preserved. Therefore, some specific information is essential, including events or adverse reactions. Objectives: To analyze the degree of reliability and completeness of medical records in relation to medical and nursing records according to selected aspects of the events or adverse events experienced by the research subjects; to verify the existence of start and end dates of events or adverse reactions reported by doctors; to observe the presence of graduation of events or adverse reactions in medical reports; to notice if there is data in medical records that relate the events or adverse reactions to the investigational drug; to identify the degree/rate of agreement between the physician and nurses reporting in the records of events or adverse reactions. Method: Documental, exploratory and descriptive study. The sample consisted of 40 charts of patients enrolled in the Brazilian National Cancer Institute who participated in clinical research protocols between 2005 and 2006. Results: 828 events were identified and only 1.5% of those which were recorded by research professionals had start and end dates, graduation, and relationship/causality; 30.3% of events were recorded in conformity by nurses and doctors. Conclusion: There are many reasons why adverse events are not efficiently captured, but efforts are needed to improve quality of clinical trial data and compliance with regulatory requirements aiming to protect research subjects. |
id |
INCA-1_5733be17e5d9ed1de421d9b6c2461b52 |
---|---|
oai_identifier_str |
oai:rbc.inca.gov.br:article/654 |
network_acronym_str |
INCA-1 |
network_name_str |
Revista Brasileira de Cancerologia (Online) |
repository_id_str |
|
spelling |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical ResearchFidedignidad y Completud de los Prontuarios Médicos con respecto a los Eventos o Reacciones Adversas en Investigación ClínicaFidedignidade e Completude dos Prontuários Médicos em Relação aos Eventos ou Reações Adversas em Pesquisa ClínicaEnsaio ClínicoToxicidade de DrogasNeoplasiasRegistros MédicosRegistros de EnfermagemClinical TrialDrug ToxicityNeoplasmsMedical RecordsNursing RecordsEnsayo ClínicoToxicidad de MedicamentosNeoplasiasRegistros MédicosRegistros de EnfermeríaIntrodution: For a clinical trial to be properly, safely and efficiently conducted, it is necessary that research integrity be preserved. Therefore, some specific information is essential, including events or adverse reactions. Objectives: To analyze the degree of reliability and completeness of medical records in relation to medical and nursing records according to selected aspects of the events or adverse events experienced by the research subjects; to verify the existence of start and end dates of events or adverse reactions reported by doctors; to observe the presence of graduation of events or adverse reactions in medical reports; to notice if there is data in medical records that relate the events or adverse reactions to the investigational drug; to identify the degree/rate of agreement between the physician and nurses reporting in the records of events or adverse reactions. Method: Documental, exploratory and descriptive study. The sample consisted of 40 charts of patients enrolled in the Brazilian National Cancer Institute who participated in clinical research protocols between 2005 and 2006. Results: 828 events were identified and only 1.5% of those which were recorded by research professionals had start and end dates, graduation, and relationship/causality; 30.3% of events were recorded in conformity by nurses and doctors. Conclusion: There are many reasons why adverse events are not efficiently captured, but efforts are needed to improve quality of clinical trial data and compliance with regulatory requirements aiming to protect research subjects. Introducción: Para que un ensayo clínico sea conducido de forma adecuada, segura y eficiente, es necesaria que la integridad de la investigación sea preservada. Por lo tanto, algunas informaciones específicas son imprescindibles, entre ellas los eventos o reacciones adversas. Objetivos: Analizar el grado de confiabilidad y de completitud de los prontuarios médicos en relación con los registros médicos y de los enfermeros de acuerdo con los aspectos seleccionados de los eventos o reacciones adversas experimentadas por los sujetos de la investigación; averiguar la existencia de fechas de inicio y término de los eventos o reacciones adversas relatadas por los médicos; observar la presencia de la graduación de los eventos o reacciones adversas en las fichas médicas; constatar si existen datos en las fichas médicas que relacionen los eventos o reacciones adversas a la droga en investigación; identificar el grado/porcentual de concordancia entre el relato del médico y del enfermero. Identificar el grado/porcentual de concordancia entre el relato médico y del enfermero en los registros de eventos o reacciones adversas. Método: Estudio documental, exploratorio, descriptivo. La casuística consistió en 40 prontuarios de pacientes apuntados en el Instituto Nacional de Cáncer que participaron en los protocolos de Investigación Clínica entre 2005 y 2006. Resultados: Fueron identificados 828 eventos y sólo el 1,5% de los registrados por los profesionales de investigación presentaban fecha de inicio y fin, graduación y relación/ causalidad; 30,3% de los eventos fueron registrados en conformidad por los enfermeros y por los médicos. Conclusión: Son muchos los motivos por los cuales los eventos adversos no son capturados de forma eficiente, sin embargo son necesarios esfuerzos para que la calidad de los datos de estudios clínicos y para que el cumplimiento de las exigencias regulatorias sean garantizadas y la protección a los sujetos de la investigación lograda. Introdução: Para que um ensaio clínico seja conduzido de forma adequada, segura e eficiente, é necessário que a integridade da pesquisa seja preservada. Portanto, algumas informações específicas são imprescindíveis, entre elas, os eventos ou reações adversas. Objetivos: Analisar o grau de fidedignidade e de completude dos prontuários médicos em relação aos registros médicos e dos enfermeiros de acordo com os aspectos selecionados dos eventos ou reações adversas experimentados pelos sujeitos de pesquisa; verificar a existência das datas de início e término dos ventos ou reações adversas relatados pelos médicos; observar a presença da graduação dos eventos ou reações adversas nos relatórios médicos; constatar se existem dados nos relatórios médicos que relacionem os eventos ou reações adversas com a droga investigacional; identificar o grau/percentual de concordância entre o relato médico e do enfermeiro nos registros de eventos ou reações adversas. Método: Estudo documental, exploratório, descritivo. A casuística constituiu-se de 40 prontuários de pacientes matriculados no Instituto Nacional de Câncer José Alencar Gomes da Silva que participaram de protocolos de Pesquisa Clínica entre 2005 e 2006. Resultados: Foram identificados 828 eventos e apenas 1,5% dos que foram registrados pelos profissionais de pesquisa apresentava data de início e fim, graduação e relação/causalidade; 30,3% dos eventos foram registrados em conformidade pelos enfermeiros e pelos médicos. Conclusão: Muitos são os motivos pelos quais os eventos adversos não são capturados de forma eficiente, porém esforços são necessários para que a qualidade dos dados de estudos clínicos e o cumprimento das exigências regulatórias sejam garantidos visando a proteger os sujeitos de pesquisa. INCA2011-12-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/65410.32635/2176-9745.RBC.2011v57n4.654Revista Brasileira de Cancerologia; Vol. 57 No. 4 (2011): Oct./Nov./Dec.; 535-540Revista Brasileira de Cancerologia; Vol. 57 Núm. 4 (2011): oct./nov./dic.; 535-540Revista Brasileira de Cancerologia; v. 57 n. 4 (2011): out./nov./dez. ; 535-5402176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/654/434Sarmento, Roberta Monteiro Batista Obadia, Renata de Castro MouraCamacho, Patrícia Gonçalves Rocha, Manuela Rios de Lima Thuler, Luiz Claudio Santos info:eu-repo/semantics/openAccess2021-11-29T20:15:36Zoai:rbc.inca.gov.br:article/654Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2021-11-29T20:15:36Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false |
dc.title.none.fl_str_mv |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research Fidedignidad y Completud de los Prontuarios Médicos con respecto a los Eventos o Reacciones Adversas en Investigación Clínica Fidedignidade e Completude dos Prontuários Médicos em Relação aos Eventos ou Reações Adversas em Pesquisa Clínica |
title |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research |
spellingShingle |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research Sarmento, Roberta Monteiro Batista Ensaio Clínico Toxicidade de Drogas Neoplasias Registros Médicos Registros de Enfermagem Clinical Trial Drug Toxicity Neoplasms Medical Records Nursing Records Ensayo Clínico Toxicidad de Medicamentos Neoplasias Registros Médicos Registros de Enfermería |
title_short |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research |
title_full |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research |
title_fullStr |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research |
title_full_unstemmed |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research |
title_sort |
Reliability and Completeness of Medical Charts as to Events or Adverse Reactions in Clinical Research |
author |
Sarmento, Roberta Monteiro Batista |
author_facet |
Sarmento, Roberta Monteiro Batista Obadia, Renata de Castro Moura Camacho, Patrícia Gonçalves Rocha, Manuela Rios de Lima Thuler, Luiz Claudio Santos |
author_role |
author |
author2 |
Obadia, Renata de Castro Moura Camacho, Patrícia Gonçalves Rocha, Manuela Rios de Lima Thuler, Luiz Claudio Santos |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Sarmento, Roberta Monteiro Batista Obadia, Renata de Castro Moura Camacho, Patrícia Gonçalves Rocha, Manuela Rios de Lima Thuler, Luiz Claudio Santos |
dc.subject.por.fl_str_mv |
Ensaio Clínico Toxicidade de Drogas Neoplasias Registros Médicos Registros de Enfermagem Clinical Trial Drug Toxicity Neoplasms Medical Records Nursing Records Ensayo Clínico Toxicidad de Medicamentos Neoplasias Registros Médicos Registros de Enfermería |
topic |
Ensaio Clínico Toxicidade de Drogas Neoplasias Registros Médicos Registros de Enfermagem Clinical Trial Drug Toxicity Neoplasms Medical Records Nursing Records Ensayo Clínico Toxicidad de Medicamentos Neoplasias Registros Médicos Registros de Enfermería |
description |
Introdution: For a clinical trial to be properly, safely and efficiently conducted, it is necessary that research integrity be preserved. Therefore, some specific information is essential, including events or adverse reactions. Objectives: To analyze the degree of reliability and completeness of medical records in relation to medical and nursing records according to selected aspects of the events or adverse events experienced by the research subjects; to verify the existence of start and end dates of events or adverse reactions reported by doctors; to observe the presence of graduation of events or adverse reactions in medical reports; to notice if there is data in medical records that relate the events or adverse reactions to the investigational drug; to identify the degree/rate of agreement between the physician and nurses reporting in the records of events or adverse reactions. Method: Documental, exploratory and descriptive study. The sample consisted of 40 charts of patients enrolled in the Brazilian National Cancer Institute who participated in clinical research protocols between 2005 and 2006. Results: 828 events were identified and only 1.5% of those which were recorded by research professionals had start and end dates, graduation, and relationship/causality; 30.3% of events were recorded in conformity by nurses and doctors. Conclusion: There are many reasons why adverse events are not efficiently captured, but efforts are needed to improve quality of clinical trial data and compliance with regulatory requirements aiming to protect research subjects. |
publishDate |
2011 |
dc.date.none.fl_str_mv |
2011-12-30 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigos, Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/654 10.32635/2176-9745.RBC.2011v57n4.654 |
url |
https://rbc.inca.gov.br/index.php/revista/article/view/654 |
identifier_str_mv |
10.32635/2176-9745.RBC.2011v57n4.654 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/654/434 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
INCA |
publisher.none.fl_str_mv |
INCA |
dc.source.none.fl_str_mv |
Revista Brasileira de Cancerologia; Vol. 57 No. 4 (2011): Oct./Nov./Dec.; 535-540 Revista Brasileira de Cancerologia; Vol. 57 Núm. 4 (2011): oct./nov./dic.; 535-540 Revista Brasileira de Cancerologia; v. 57 n. 4 (2011): out./nov./dez. ; 535-540 2176-9745 reponame:Revista Brasileira de Cancerologia (Online) instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
instname_str |
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
instacron_str |
INCA |
institution |
INCA |
reponame_str |
Revista Brasileira de Cancerologia (Online) |
collection |
Revista Brasileira de Cancerologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
repository.mail.fl_str_mv |
rbc@inca.gov.br |
_version_ |
1797042245251104768 |